APP and benign essential blepharospasm: Furthermore, to determine whether the combined management of BoNT-A and APP have a joint effect on the improvement of dry eye in blepharospasm patients, we compared the changing rates of OSDI, FL, FBUT and SIT between the BoNT-A group and the BoNT-A+APP group after 4–6 weeks of treatment.